Cargando…
Mucormycosis following COVID-19 infection-An epidemic developing in a pandemic, a case series from a tertiary care hospital of India
When the world is still struggling to fight the Coronavirus disease-19 pandemic, an epidemic of mucormycosis following the COVID-19 infection is increasing in India. Mucormycosis is a rare life-threatening fungal infection with a high mortality rate. Is this increase due to the rampant usage of cort...
Autores principales: | Singhai, Abhishek, Unnikrishnan, Sooraj, Jain, Pragya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067224/ https://www.ncbi.nlm.nih.gov/pubmed/35516677 http://dx.doi.org/10.4103/jfmpc.jfmpc_1125_21 |
Ejemplares similares
-
Mucormycosis in post-covid patients: An epidemic in pandemic
por: Kesarwani, Vasudha, et al.
Publicado: (2022) -
Anaesthetic concerns in post-COVID mucormycosis at a tertiary care hospital in India: An observational study
por: Lahiri, Swati, et al.
Publicado: (2023) -
Mucormycosis in two community hospitals and the role of infectious disease consultation: a case series
por: Dai, Yue, et al.
Publicado: (2013) -
Legions of Presentations of Myxedema Coma: A Case Series from a Tertiary Hospital in India
por: Roy, Nirmalya, et al.
Publicado: (2020) -
Mucormycosis in COVID-19 pandemic: study at tertiary hospital in India
por: Chavan, Reshma P., et al.
Publicado: (2022)